适应性平台试验设计的关键考量:第二部分
本文为两部分系列文章的第二部分,基于作者规划与启动适应性平台试验(APTs)的经验,以叙述性综述形式提供规划APTs的关键考量。第二部分涵盖统计学与性能、其他设计特征、数据基础设施、运营与组织、资金、传播及实施共7个方面。
要点
- APTs为遵循核心方案、持续添加干预措施的复杂随机对照试验,可长期运行评估多种干预。
- 规划APTs需统筹统计学与性能、数据基础设施、运营组织及资金等多维度考量。
- 本文提供的规划考量可为拟开展APTs的研究者提供参考。
核心结论
- 本文提供的APTs规划关键考量指导,有助于研究者考虑或规划适应性平台试验。
研究设计与样本
- 本文为叙述性综述,基于作者自身规划与启动适应性平台试验的经验,聚焦临床情境下APTs规划的关键考量。
主要发现
- 第二部分涵盖7个总体考量:统计学与性能、其他设计特征、数据基础设施、运营与组织、资金、传播及实施。
- 第一部分涵盖5个总体考量:利益相关者参与、人群与场景、干预与对照、临床结局及适应性调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: There is an increased interest in adaptive platform trials (APTs), that is, complex randomized clinical trials (RCTs) focusing on a population or a setting, conducted according to a core protocol, with continuous addition of interventions during trial conduct. APTs may run perpetually, assessing many different interventions. APTs come with benefits regarding increased flexibility, efficiency, and cost-effectiveness compared to conventional, stand-alone RCTs. However, planning APTs is complex, and limited guidance is available. METHODS: In this two-part series, we provide a narrative overview of key considerations for the planning of APTs in a clinical setting based on our own experiences planning and initiating APTs. RESULTS: The first part covered the following 5 overall considerations: stakeholder involvement, population and setting, interventions and comparisons, clinical outcomes, and adaptations. This second part covers 7 overall considerations: statistics and performance, other design features, data infrastructure, operations and organization, funding, dissemination, and implementation. CONCLUSION: The provided guidance on key considerations when planning APTs will aid researchers considering or planning APTs.
引用
- Granholm A, Møller MH, Rosso A, et al. Key considerations for planning adaptive platform trials: part 2. J Clin Epidemiol. 2026. PMID: 41796758. doi:10.1016/j.jclinepi.2026.112213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。